A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

NCT01975324 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Non Arteritic Ischemic Optic Neuropathy

Interventions

DRUG: dalfampridine
DRUG: Placebo

Sponsor

Neuro-Ophthalmologic Associates, PC

Collaborators

[object Object]